REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PharmaEssentia Corp. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PharmaEssentia Corp. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

PharmaEssentia Corporation is a bio-pharmaceutical company. The company is engaged in the research, development and manufacture of therapeutic products. The company was incorporated in 2003 and is headquartered in Taiwan.

Headquarters
13F, No.3, Yuanqu St., Nankang Dist
Taipei City; Taipei City;

Contact Details: Purchase the PharmaEssentia Corp. report to view the information.

Website: http://www.pharmaessentia.com

Basic Information
Total Employees:
Purchase the PharmaEssentia Corp. report to view the information.
Outstanding Shares:
Purchase the PharmaEssentia Corp. report to view the information.
Financial Auditors:
Purchase the PharmaEssentia Corp. report to view the information.
Incorporation Date:
May 09, 2000
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
6.49%
Purchase this report to view the information.
2.84%
Purchase this report to view the information.
1.83%
Purchase this report to view the information.
1.16%
Purchase this report to view the information.
0.89%
Subsidiaries
Pharma Essentia Japan Kk (Japan)
100%
Pharma Essentia Usa Llc (United States)
100%
Pharmaessentia Innovation Research Center, Inc. (United States)
100%
Company Performance
Financial values in the chart are available after PharmaEssentia Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
77.15%▲
Total operating revenue
77.87%▲
Operating profit (EBIT)
6.27%▲
EBITDA
-1.79%▼
Net Profit (Loss) for the Period
54.62%▲
Total assets
77.85%▲
Total equity
97.25%▲
Operating Profit Margin (ROS)
33.14%▲
Net Profit Margin
35.48%▲
Return on Equity (ROE)
8.72%▲
Debt to Equity Ratio
-3.79%▼
Quick Ratio
5.15%▲
Cash Ratio
5.1%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
Pharmally International Holding Co., Ltd
 
Taiwan Biotech Co., Ltd.
Yung Shin Pharm. Ind. Co., Ltd.
 
Formosa Laboratories, Inc.
ShareHope Medicine Co., Ltd.
 
Universal Vision Biotechnology Co., Ltd.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo